Genetically altering a patient’s immune cells has, for the first time, produced remissions in adults with a deadly type of acute leukemia. In one patient, all trace of the disease vanished in 8 days.
By DENISE GRADY, New York Times
Wed, 03/20/2013 - 11:07am
Genetically altering a patient’s immune cells has, for the first time, produced remissions in adults with a deadly type of acute leukemia. In one patient, all trace of the disease vanished in 8 days.